Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Ceftobiprole

    Client Email Product

    Ceftobiprole

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    MARKET PLACE

    DIGITAL CONTENT

    PharmaCompass
    Related ProductsRelated Products
    API SUPPLIERS
    API Suppliers

    API Suppliers

    1
    US DMFs Filed

    US DMFs Filed

    0

    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    0

    Other Suppliers

    Other Suppliers

    1
    API REF. PRICE (USD / KG)

    0

    API Market Place

    3
    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    0

    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    0

    USFDA Exclusivities

    0

    DIGITAL CONTENT

    Blog #PharmaFlow

    0

    News

    12
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    Basilea reports new data for Zevtera presented at US IDWeek Congress 2023
    Basilea reports new data for Zevtera presented at US IDWeek Congress 2023

    https://www.globenewswire.com//news-release/2023/10/17/2761159/0/en/Basilea-reports-new-data-for-ceftobiprole-Zevtera-presented-at-US-IDWeek-Congress-2023.html

    GLOBENEWSWIRE
    17 Oct 2023
    Share Share
    Basilea announces publication of phase 3 data on ceftobiprole
    Basilea announces publication of phase 3 data on ceftobiprole

    https://www.globenewswire.com//news-release/2023/09/28/2750877/0/en/Basilea-announces-New-England-Journal-of-Medicine-publication-of-phase-3-data-on-ceftobiprole-for-the-treatment-of-Staphylococcus-aureus-bacteremia.html

    GLOBENEWSWIRE
    28 Sep 2023
    Share Share
    Basilea announces submission of a NDA to the US FDA for antibiotic ceftobiprole
    Basilea announces submission of a NDA to the US FDA for antibiotic ceftobiprole

    https://www.globenewswire.com/news-release/2023/08/04/2718726/0/en/Basilea-announces-submission-of-a-New-Drug-Application-to-the-US-Food-and-Drug-Administration-for-its-antibiotic-ceftobiprole.html

    GLOBENEWSWIRE
    04 Aug 2023
    Share Share
    Basilea provides update on NEW to the USFDA for antibiotic ceftobiprole
    Basilea provides update on NEW to the USFDA for antibiotic ceftobiprole

    https://www.globenewswire.com/news-release/2023/04/18/2648585/0/en/Basilea-provides-update-on-New-Drug-Application-to-the-US-Food-and-Drug-Administration-for-antibiotic-ceftobiprole.html

    GLOBENEWSWIRE
    18 Apr 2023
    Share Share
    ERADICATE phase 3 study results highlight the potential role of ceftobiprole
    ERADICATE phase 3 study results highlight the potential role of ceftobiprole

    https://www.globenewswire.com/news-release/2022/10/24/2539639/0/en/ERADICATE-phase-3-study-results-highlight-the-potential-role-of-ceftobiprole-in-the-treatment-of-Staphylococcus-aureus-bacteremia-SAB.html

    GLOBENEWSWIRE
    24 Oct 2022
    Share Share
    Basilea announces Zevtera (ceftobiprole) marketing authorization in Brazil
    Basilea announces Zevtera (ceftobiprole) marketing authorization in Brazil

    https://www.globenewswire.com/news-release/2022/07/12/2477718/0/en/Basilea-announces-Zevtera-ceftobiprole-marketing-authorization-in-Brazil.html

    GLOBENEWSWIRE
    11 Jul 2022
    Share Share
    Basilea's positive results of PIII ERADICATE study with ceftobiprole in SAB
    Basilea's positive results of PIII ERADICATE study with ceftobiprole in SAB

    https://www.globenewswire.com/news-release/2022/06/28/2469971/0/en/Basilea-announces-positive-results-of-phase-3-ERADICATE-study-with-ceftobiprole-in-Staphylococcus-aureus-bacteremia-SAB.html

    GLOBENEWSWIRE
    27 Jun 2022
    Share Share
    Basilea completes patient enrollment in phase 3 study investigating ceftobiprole
    Basilea completes patient enrollment in phase 3 study investigating ceftobiprole

    https://www.globenewswire.com/news-release/2022/01/11/2364482/0/en/Basilea-announces-completion-of-patient-enrolment-in-phase-3-ERADICATE-study-investigating-ceftobiprole-in-bloodstream-infections.html

    GLOBENEWSWIRE
    10 Jan 2022
    Share Share
    Basilea announces distribution agreement with JSC Lancet
    Basilea announces distribution agreement with JSC Lancet

    https://www.globenewswire.com/news-release/2021/07/14/2262428/0/en/Basilea-announces-distribution-agreement-with-JSC-Lancet-for-antibiotic-Zevtera-ceftobiprole-covering-Russia-and-the-Eurasian-Economic-Union.html

    GLOBENEWSWIRE
    14 Jul 2021
    Share Share
    Global MRSA Drugs Market to Surpass US$ 1.3 Billion by 2026
    Global MRSA Drugs Market to Surpass US$ 1.3 Billion by 2026

    https://www.businesswire.com/news/home/20190924005553/en

    BUSINESSWIRE
    24 Sep 2019
    Share Share
    Basilea bags $72m upfront from Pfizer for antifungal license
    Basilea bags $72m upfront from Pfizer for antifungal license

    http://www.pmlive.com/pharma_news/basilea_bags_$72m_upfront_from_pfizer_for_antifungal_license_1195756

    Phil Taylor PMLIVE
    16 Jun 2017
    Share Share
    Basilea dumps its $190M IPO plan as the U.S. market sputters
    Basilea dumps its $190M IPO plan as the U.S. market sputters

    http://www.fiercebiotech.com/story/basilea-dumps-its-190m-ipo-plan-us-market-sputters/2015-12-09

    Damian Garde FIERCE BIOTECH
    09 Dec 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search